Atroposelective Suzuki–Miyaura Coupling to Form 2‐Amino‐2′‐Hydroxybiphenyls Enabled by sRuPhos

H Hamzah Sharif (Yusuf Hamied Department of Chemistry University of Cambridge Cambridge UK) L Luke A. McCall (Yusuf Hamied Department of Chemistry University of Cambridge Lensfield Road Cambridge CB2 1EW UK) M Matthew G. Sanders (Oncology Targeted Discovery, Oncology R&D AstraZeneca The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue Cambridge CB2 0AA UK) R Robert J. Phipps (Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, U.K.)

Abstract

Abstract Atropisomeric biaryls are increasingly important in molecules of pharmaceutical interest. Asymmetric versions of the Suzuki–Miyaura coupling arguably constitute the most direct and attractive route to these without resorting to wasteful preparative separations or resolution steps. Herein, we report a new chiral phosphine ligand sRuPhos, a sulfonated form of RuPhos, which permits the coupling of unprotected ortho ‐bromoanilines and ortho ‐phenolic boronate esters with extremely high ee (up to 99%) to form 2‐amino‐2′‐hydroxybiphenyls. N ‐alkylation can be accommodated on the aniline nitrogen and sRuPhos is also able to form highly hindered 2,2′‐biphenols, which could not be achieved in our previous studies using the related chiral ligand sSPhos. Given the great importance of biaryl atropisomers in medicinal chemistry, as well as the potential utility of the 2‐amino‐2′‐hydroxybiphenyl motif in chiral catalyst design, we anticipate that this reaction will soon find utility and that sRuPhos may be a useful ligand in the development of other asymmetric palladium‐catalysed processes.

Article Details

Volume / Issue Vol. 65, Issue 8
Published February 16, 2026
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (4)

H

Hamzah Sharif

Yusuf Hamied Department of Chemistry University of Cambridge Cambridge UK

L

Luke A. McCall

Yusuf Hamied Department of Chemistry University of Cambridge Lensfield Road Cambridge CB2 1EW UK

M

Matthew G. Sanders

Oncology Targeted Discovery, Oncology R&D AstraZeneca The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue Cambridge CB2 0AA UK

R

Robert J. Phipps

Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, U.K.